Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.77B |
| 2 |
McKesson
MCK
|
+$2.38B |
| 3 |
SPCX
SpaceX
SPCX
|
+$2.3B |
| 4 |
HONA
Honeywell Aerospace
HONA
|
+$2.05B |
| 5 |
Amazon
AMZN
|
+$1.37B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.96B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$3.11B |
| 3 |
Honeywell
HON
|
+$1.96B |
| 4 |
Salesforce
CRM
|
+$1.47B |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$775M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.63% |
| 2 | Financials | 9.78% |
| 3 | Healthcare | 7.32% |
| 4 | Industrials | 7.25% |
| 5 | Consumer Discretionary | 7.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Invesco BulletShares 2030 Corporate Bond ETF
BSCU
$2.71B
| $182M | 0.01% |
10,913,052
+224,744
| +2% | +$3.75M |
|
1102
Haleon
HLN
$44.7B
| $182M | 0.01% |
19,461,762
+295,509
| +2% | +$2.75M |
|
1103
Charles River Laboratories
CRL
$14.1B
| $182M | 0.01% |
800,487
-25,181
| -3% | -$4.48M |
|
1104
Global X Uranium ETF
URA
$6.74B
| $181M | 0.01% |
4,151,983
+950,590
| +30% | +$48.1M |
|
1105
PIMCO Short Term Municipal Bond Active Exchange-Traded Fund
SMMU
$1.18B
| $180M | 0.01% |
3,573,247
+283,722
| +9% | +$14.3M |
|
1106
Las Vegas Sands
LVS
$29.9B
| $180M | 0.01% |
3,903,863
-88,551
| -2% | -$4.59M |
|
1107
Bentley Systems
BSY
$11.2B
| $180M | 0.01% |
6,027,027
-62,933
| -1% | -$2.05M |
|
1108
Old National Bancorp
ONB
$9.86B
| $180M | 0.01% |
6,950,155
-722,449
| -9% | -$17.4M |
|
1109
iShares MSCI Canada ETF
EWC
$6.91B
| $180M | 0.01% |
3,120,931
-66,982
| -2% | -$3.88M |
|
1110
T. Rowe Price Capital Appreciation Equity ETF
TCAF
$8.32B
| $180M | 0.01% |
4,374,634
+301,956
| +7% | +$11.9M |
|
1111
First Trust Managed Municipal ETF
FMB
$2.04B
| $180M | 0.01% |
3,496,125
+155,906
| +5% | +$7.97M |
|
1112
NatWest
NWG
$74.5B
| $179M | 0.01% |
10,176,295
+1,770,115
| +21% | +$28.5M |
|
1113
Hudbay
HBM
$13.3B
| $179M | 0.01% |
7,566,399
+743,774
| +11% | +$18.8M |
|
1114
Eaton Vance Short Duration Municipal Income ETF
EVSM
$814M
| $179M | 0.01% |
3,549,162
+30,665
| +0.9% | +$1.54M |
|
|
FPF
1115
First Trust Intermediate Duration Preferred & Income Fund
FPF
$1.08B
| $178M | 0.01% |
9,820,464
+74,695
| +0.8% | +$1.35M |
|
1116
First Trust Developed Markets ex-US AlphaDEX Fund
FDT
$1.31B
| $178M | 0.01% |
1,883,655
+619,587
| +49% | +$59.2M |
|
1117
Invesco BulletShares 2029 Corporate Bond ETF
BSCT
$2.95B
| $178M | 0.01% |
9,596,451
+659,715
| +7% | +$12.3M |
|
1118
iShares Latin America 40 ETF
ILF
$3.77B
| $178M | 0.01% |
5,280,873
+192,920
| +4% | +$6.84M |
|
1119
T. Rowe Price US Equity Research ETF
TSPA
$4.48B
| $178M | 0.01% |
3,747,072
-9,837
| -0.3% | -$451K |
|
1120
Trade Desk
TTD
$6.12B
| $178M | 0.01% |
9,849,697
+1,082,137
| +12% | +$23M |
|
1121
NNN REIT
NNN
$8.76B
| $177M | 0.01% |
3,810,780
+885,619
| +30% | +$39.5M |
|
1122
WisdomTree International Hedged Quality Dividend Growth Fund
IHDG
$2.21B
| $176M | 0.01% |
3,364,175
-55,495
| -2% | -$2.82M |
|
1123
Imperial Oil
IMO
$63.6B
| $176M | 0.01% |
1,571,125
-63,561
| -4% | -$7.96M |
|
1124
Henry Schein
HSIC
$10.1B
| $175M | 0.01% |
2,100,819
+674,121
| +47% | +$51.5M |
|
1125
Immunovant
IMVT
$9.07B
| $175M | 0.01% |
4,534,833
+657,956
| +17% | +$20M |
|
Similar funds
Morgan Stanley's Q2 2026 Portfolio in Review
As of Q2 2026, Morgan Stanley held 8,715 positions worth $1.89T, up 14% from $1.66T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Morgan Stanley's Q2 2026 filing shows 423 new, 3,809 increased, 3,216 reduced and 305 closed positions. Its largest new stake was SpaceX: 13,532,773 shares worth $2.31B. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.96B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
- Morgan Stanley's largest Q2 2026 buy was SpaceX: 13,532,773 shares worth $2.31B.
- Morgan Stanley added most to NVIDIA in Q2 2026, an estimated $2.77B increase.
- Morgan Stanley's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.96B.
- Morgan Stanley fully exited Apellis Pharmaceuticals in Q2 2026, selling an estimated $404M.
- Morgan Stanley's ten largest holdings make up 21% of its $1.89T portfolio in Q2 2026.
- Morgan Stanley opened 423 new positions and closed 305 in Q2 2026.
- Morgan Stanley's portfolio value rose 14% quarter-over-quarter to $1.89T.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.